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Summary. Ataxia-telangiectasia (A-T) is a progressive 
autosomal recessive disease featuring neurodegenera- 
tion, immunodeficiency, hromosomal instability, radia- 
tion sensitivity and a highly increased proneness to can- 
cer. A-T is ethnically widespread an genetically hetero- 
geneous, as indicated by the existence of four comple- 
mentation groups in this disease, Several "A-T-like" ge- 
netic diseases hare various clinical and cellular charac- 
teristics with A-T. By using linkage analysis to study 
North American and Turkish A-T families, the ATA 
(A-T, complementation group A) gene has been mapped 
to chromosome 11q23. A number of Israeli Arab A-T 
patients coming from large, highly inbred families were 
assigned to group A. In one of these families, an addi- 
tional autosomal recessive disease was identified, char- 
acterized by ataxia, hypotonia, microcephaly and bilat- 
eral congenital cataracts. In two patients with this syn- 
drome, normal levels of serum immunoglobulins and 
alpha-fetoprotein, chromosomal stability in peripheral 
blood lymphocytes and skin fibroblasts, and normal cel- 
lular response to treatments with X-rays and the radio- 
mimetic drug neocarzinostatin indicated that this disease 
does not share, with A-T, any additional features other 
than ataxia. These tests also showed that another patient 
in this family, who is also mentally retarded, is affected 
with both disorders. This conclusion was further sup- 
ported by linkage analysis with 11@3 markers. Lod 
scores between A-T and these markers, cumulated over 
three large Arab families, were significant and confirmed 
the localization of the ATA gene to 11@3. However, 
another Druze family unassigned to a specific comple- 
mentation group, showed several recombinants between 
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A-T and the same markers, leaving the localization of 
the A-T gene in this family open. 
Introduction 
Ataxia-telangiectasia (A-T) is an autosomal recessive 
disease xpressed as cerebellar degeneration, telangiec- 
tasia, immune deficiency, chromosomal instability, in- 
creased tendency to lymphoreticular malignancies, and 
radiosensitivity (Boder 1985; Cohen and Levy 1989; 
McKinnon 1987). Cultured A-T cells show elevated chro- 
mosomal breakage and rearrangements, increased sen- 
sitivity to ionizing radiation and radiomimetic chemicals, 
and a decreased inhibition of DNA synthesis after treat- 
ment with these agents (McKinnon 1987; Shiloh et al. 
1985; Taylor 1982). To a limited extent, A-T heterozy- 
gotes also show a proneness to cancer and cellular hyper- 
sensitivity to the same DNA damaging agents (Arlett 
and Priestley 1985; Morrell et al. 1986; Paterson et al. 
1985; Shiloh et al. 1983; Swift 1985). 
A-T is ethnically widespread, with an average fre- 
quency of 1 : 40000 live births in Caucasian populations 
(Spector et al. 1982; Swift et al. 1986). Genetic hetero- 
geneity in A-T is indicated by the existence of 4 com- 
plementation groups (A, C, D, and E), defined by in 
vitro studies (Jaspers et al. 1988a). In addition, anumber 
of genetic syndromes display some of the clinical and cel- 
lular characteristics of A-T, usually with additional fea- 
tures (Curry et al. 1989; Fiorilli et al. 1985; Jaspers et al. 
1988b; Seemanov~ 1990; Taalman et al, 1989; Taylor et 
al. 1987; Ziv et al. 1989). The relationship between A-T 
und these "A-T like" syndromes i  not clear. 
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Linkage studies recently led to the assignment of two 
A-T  genes, ATA (A-T, group A) and ATC (A-T, group 
C), to the chromosomal  region 11@3 (Gatti et al. 1988; 
McConvil le et al. 1990a, b; Sanal et al. 1990; Ziv et al. 
1991). These results are expected to help to clarify the 
genetic and molecular basis of A -T  and the "A-T-l ike" 
syndromes. 
A-T has been found in Israel among Moroccan Jewish, 
Arab,  Bedouin and Druze families. Complementat ion 
studies assigned several Moroccan Jewish pedigrees to 
group C and Arab pedigress to group A (Jaspers et al. 
1988 and unpublished results). Bedouin and Druze fami- 
lies have not yet been assigned. The Arab A-T  pedigrees 
are large and characterized by much inbreeding. In view 
of the ethnic distribution and genetic heterogeneity of 
A-T, we performed linkage analysis in Arabs and Druze,  
to confirm the localization of the A-T  locus to 11q23 in 
these ethnic groups. An  additional autosomal recessive 
disease was identified in one of the Arab  families with 
A-T, involving ataxia, microcephaly and congenital cata- 
ract, We examine here the possible relationship between 
the two diseases, using a combination of linkage analysis 
and comparative studies of the immunologic, cytogenet- 
ic and cellular phenotypes of two types of  patients in this 
family. 
Subjects and methods 
Patients and families 
One Druze and three Arab A-T families were studied (Fig. 1). Ini- 
tial diagnosis of A-T based on clinical examination was confirmed 
by measurements of serum immunoglobulins and alpha fetopro- 
tein, cytogenetic analysis of peripheral blood tymphocytes and skin 
fibroblasts, and an assessment of the sensitivity of skin fibroblasts 
to ionizing radiation a d the radiomimetic drug neoncarzinostatin 
(NCS). Six children in family ISAT9 (Fig. 1) had A-T. Three other 
children, VI-3, VI-4 and VI-14 (aged 3.7, 1.3 and 2.3 years, re- 
spectively, at the time of examination), showed adifferent disease, 
apparently inherited in an autosomal recessive manner and charac- 
terized by ataxia, hypotonia, microcephaly, bilateral congenital 
cataracts and searching nystagmus. Patient VI-3 also had bluish 
irises and moderate psychomotor retardation. Patients VI-4 and 
VI-14 were of normal intelligence. No telangiectases were ob- 
served. 
Cell cultures 
Primary fibroblast cell lines were established from skin biopsies 
obtained following informed consent; they were grown in Dul- 
becco's modified Eagle medium with 10% fetal bovine serum (Beit 
Ha'Emek, Israel). 
Cytogenetic analysis 
Lymphocytes. Chromosome spreads were prepared from 0.1ml 
peripheral blood as described by Schwarzacher and Wolf (1974). 
Chromosomal damage was scored according to Cohen et al. (1967) 
and expressed as the number of chromatid breaks per cell. Struc- 
tural rearrangements were considered to represent 2 chromatid 
breaks. 
Fibroblasts. Monolayer cultures were split at a ratio of 1:3, and 
the cells were seeded onto coverslips, 2 days later. Colcemid was 
added to the cultures for 50 rain, the cells were collected and chro- 
mosome spreads were prepared. G-banding was performed ac- 
cording to Ktinger (1987). 
Cellular sensitivity to DNA damaging agents 
Fibrobtast monolayers atthe late logarithmic phase were treated at 
37°C for 20 min with various concentrations of NCS (Kayaku Anti- 
biotics, Tokyo) in phosphate-buffered saline. The cultures were 
then trypsinized and replated at densities of 100-5000 cells per 
50 mm dish in order to assay their colony-forming ability. 
Inhibition of DNA synthesis by ionizing radiation 
Fibroblasts were plated in 30 mm dishes (70000 cells/dish). A day 
later, their DNA was prelabelled by adding i4 C-thymidine (50 mCi/ 
mmole; 0.03 I~Ci/ml), and incubation was continued for 16 h. Fol- 
lowing exposure to various doses of X-rays, 3H-thymidine (25 Ci/ 
Table 1. DNA probes and polymorphisms u ed in this study 
Locus Probe Enzyme Alleles Allele Source (reference) 
(kb) fi'equency 
DllS84 p2.71D6 TaqI 6.4 0.24 
4.2 0.76 
STMY psp64 TaqI 4.6 0.52 
2.1, 1.0 0.48 
D 11S1.32 CRI-L424 HindIII 2.9 0.60 
1.9 O.40 
DllS144 pYNB3.12 MspI 2.9 0.53 
2.6 0.47 
DtlS351 CJ52.208 MspI 4.0 0.41 
3.2 0.59 
CD3G PT3dH MspI 2.5 0.80 
1.7, 0.8 0.20 
DllS29 L7 TaqI 10.9 0.79 
13.9 0.21 
D11424 CJ52.77 MspI 7.3 0.25 
6.8 0.75 
M. Litt (Maslem et al. 1987) 
N. K. Spurr (Spurr et al. 1988) 
Collaborative Research, Inc. (Donis-Keller t aI. 1987) 
Y. Nakamura (Carlson et al. 1988) 
M. Lathrop (Julier et al. 1990) 
R. A. Gatti (Charmley et al. 1989) 
E. Dietzch (Warnich et al. 1986) 
M. Lathrop (Julier et al. 1990) 
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Fig. 1. Pedigrees of the families analyzed. 
Families ISAT1, ISAT3 and ISAT9 are 
Arab. Family ISAT8 is Druze. L • A-T 
patients; ~il, ~ A-T heterozygotes 
mmole; 2.5 gCi/ml) was added and incubation was continued at 
37°C for 3 h. The pH of the cultures was maintained at 7.4 through- 
out the labeling period by the presence of 20 mM HEPES. The 
cells were harvested by scraping, and the ratio of 3H to I4C in tri- 
chloroacetic acid precipitates was used to measure the rate of 
DNA synthesis. 
Southern blotting 
DNA was isolated from fibroblast cultures according to standard 
methods (Sambrook et al. 1989), and cleaved with restriction en- 
donuclease under the conditions recommended by the manufactur- 
ers. The fragments were separated by el ctrophoresis in 0.6%- 
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0.8% agarose g ls and transferred to Nytran membranes (Schlei- 
cher and Schuell), according to Southern (1975). Probes (Table 1)
were labeled by random priming (Feinberg and Vogelstein 1983). 
Hybridization and autoradiography were performed as described 
by Sakai et al. (1985). 
Linkage analysis 
All linkage calculations were performed by the pedigree analysis 
program MENDEL (Lange et al. 1988). This program is especially 
appropriate for large inbred pedigrees because of the efficient way 
in which it handles inbreeding (Lange and Boehnke 1983), and its 
systematic elimination of superfluous genotypes conducted inter- 
nally prior to likelihood calculations (Lange d Goradia 1987). 
Results 
Relationship between the two diseases in family ISA T9 
The two genetic diseases that segregate in this family 
(Fig. 1) apparently share a common feature, ataxia. It 
was of interest o determine whether they share addi- 
tional phenotypic features, which would point o the 
possible identity of the genes that determine them. This 
was particularly important for linkage analysis in this 
family since, if both diseases are determined by genes re- 
siding at the same locus, a combined lod score should be 
greater than either of the two separate lod scores. 
Table 2 summarizes the immunologic haracteriza- 
tion of the A-T patient VI-2, and of those with ataxia- 
microcephaly-cataract (AMC). The A-T patient showed 
a significant reduction in IgA and elevation of alpha- 
fetoprotein levels in her serum, both characteristic of A- 
T. The three patients with AMC varied: VI-3 resembled 
her sister with A-T, whereas VI-4 and VI-14 showed 
normal values of alpha fetoprotein and immunoglobu- 
lins. The same was true when chromosomal stability was 
tested in their lymphocytes and fibroblasts (Table 3): 
again, both VI-2 and VI-3 showed an A-T phenotype, 
expressed as high chromosomal breakage, whereas VI-4 
and VI-14 showed normal chromosomal stability. 
Two additional features of the cellular A-T pheno- 
type are increased sensitivity to the lethal action of 
ionizing radiation and radiomimetic chemicals, and de- 
creased inhibition f DNA synthesis by these agents. 
Figure 2 shows the response of fibroblast cell lines from 
several affected individuals of the family to increasing 
doses of the radiomimetic drug NCS, as measured by 
their colony-forming ability. Whereas cells from VI-3 
demonstrated an extreme hypersensitivity to NCS, like 
those of her sister with A-T (VI-2), the other two pa- 
tients with AMC showed an intermediate r sponse, typi- 
cal of A-T heterozygotes (Shiloh et al. 1982, 1983). Fi- 
nally, when the inhibition of DNA synthesis by X-rays 
was tested, VI-3 again showed a response that was indis- 
tinguishable from that of A-T patients, whereas the 
other two AMC patients demonstrated a normal re- 
sponse (Fig. 3). 
These results suggest that: 1) the two diseases do not 
share additional recognizable features in addition to 
ataxia: 2) VI-3 is most probably affected by both disor- 
ders, whereas VI-4 and VI-14 have only AMC. The lat- 
ter assumption was further tested by performing linkage 
analysis in the family, using DNA markers from the re- 
1.0- 
Table 2. Immunoglobulin and alpha-fetoprotein levels in the 
serum of various members of family ISAT9. MR, Mental retarda- 
tion 
Sub- Cl in ical  Immunoglobulins (mg/dl) Alpha- 
ject phenotype fgA IgG IgM feto- 
protein 
(ng/ml) 
VI-2 A-T 7 1510 110 87 
VI-3 AMC + MR 10 1225 145 40 
VI-4 AMC 45 980 90 8 
VI-14 AMC 160 t800 90 6.5 
Normal range: 25-140 520-1450 40-200 2-20 
Table 3. Chromosomal instability in cellsfrom four members of 
family ISAT9. MR, Mental retardation 
Subject Clinical phenotype Chromatide breaks/cell 
LDnpho- Fibro- 
cytes blasts 
VI-2 A-T 0.26 0.71 
VI-3 AMC + MR 0.30 0.63 
VI -4 AMC 0 0.03 
VI-14 AMC 0.01 0.02 
2-- 
2 
g 
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Fig. 2. Survival curves of fibroblast cell lines following treatment 
with various doses of NCS. • Normal control; the other symbols 
denote members of family ISAT9:VI -2  (&), VI -3 (O), Vt -4  ([3), 
and VI-14 (ZX) 
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Fig. 3. Inhibition of DNA synthesis by increasing doses of X-irradi- 
ation in fibroblast cell lines, i, AT5LA, an A-T (group A) cell 
line; • CR70, a normal control; o her symbols denote members of 
family ISAT9:VI-2 (©), VI-3 (<)), VI-4 (A) and VI- 14 (rT) 
Table 4. Lod scores between A-T and 11@3 loci in family ISAT9 
obtained for different genotypic assignments 
Marker Affected individuals in generation VI 
loci 2,5,6,8, 2,3,5,6,8, 
10, 11 10, 11 
0 Z 0 Z 
2,3,4,5,6, 
8, 10, 11, 14 
0 Z 
STMY 0.13 1.942 0.061 3.011 0.27 0.792 
DllS84 0.5 0 0.022 0.426 0.5 0 
DllS351 10 -6 0.595 10 -6 1.072 0.5 0 
DllS29 0.14 0.824 0.11 1.185 0.24 0.574 
CD3G 0.22 0.573 0.18 0.756 0.23 0.543 
DllS424 0.116 0.603 10 6 2.140 0.5 0 
gion 11q23. Initial analysis was performed with only A-T 
patients being considered as affected (Table 4, right col- 
umn). The lod score obtained with the marker STMY 
was suggestive of linkage. Lod scores were then calcu- 
lated for two additional genotypic models: 1) A-T pa- 
tients plus VI-3 are affected; 2) all the patients, with 
either A-T or AMC, are affected. With 6 markers from 
the 11@3 region, the highest lod scores for the family 
were obtained when A-T patients plus VI-3 were con- 
sidered as being affected (Table 4, middle column). The 
addition of VI-4 and VI-14, or the elimination f VI-3, 
reduced the lod scores and increased the genetic distance 
between the disease locus and each marker (Table 4). 
The lod scores obtained with the marker STMY for the 
second model was significant (> 3.0). Taken together, 
these results indicate that, in this family, as in European 
and American A-T families, the A-T locus is located at 
11q23, and AMC is not linked to A-T. Individual VI-3 
is apparently affected by both diseases, whereas VI-4 
and VI-14 are affected with AMC alone, and are proba- 
bly also A-T carriers. 
Linkage analysis with 11q23 markers 
Table 5 presents lod scores between A-T and various 
11q23 markers for each family separately, and cumulative 
values for the 3 Arab families known to be of group A. 
The results are in agreement with previous data obtained 
with group A families in Turkey and USA (Gatti et al. 
1988; Sanal et al. 1990). Significant cumulative lod scores 
were obtained with the loci STMY, DllS132, DllS144, 
DllS351 and DllS424, in the Arab families. No recom- 
bination events were noticed between A-T and the latter 
four markers. DllS132, DllS144 and DLIS351 did, how- 
ever, recombine with the disease in the Druze family 
ISAT8; this might reflect a recombination event distal to 
A-T, or a different localization of the disease locus in 
this family. 
Discussion 
Three individuals in family ISAT9 had ataxia, hypoto- 
nia, microcephaly and congenital cataracts with nystag- 
mus; mental retardation was also observed in one of these 
individuals. These findings resemble the Marinesco-Sjor- 
gen syndrome (MSS), which is characterized by cerebel- 
lar ataxia, congenital cataracts and mental retardation 
(Sjorgen 1950; Todorov 1965). However, microcephaly 
is not part of MSS, and mental retardation was present 
in only one of the three AMC patients in family ISAT9. 
In view of the young age of these patients and the possi- 
bility that the disease is progressive, a longer period of 
follow up is required before AMC can be defined as a 
new clinical entity. 
The occurrence, in the same family, of two autosomal 
recessive diseases haring clinical characteristics raises 
the possibility of a physiologic or genetic relationship be- 
tween the two. The variety of genetic syndromes involv- 
ing different combinations of A-T features has raised 
some speculation regarding putative genetic loci com- 
mon to these seemingly related iseases (Ziv et al. 1989). 
Salient features in these diseases include chromosomal 
instability, immunodeficiency and radiation sensitivity. 
However, whereas some of these entities are dearly dif- 
ferent from A-T (Byrne et al. 1984; Maraschio et al. 
1986; Maserati et al. 1988; Wegner et al. 1988), others 
are regarded as "variants" of A-T (Taylor et al. 1987; 
Ziv et al. 1989). Of particular interest are the Nijmegen 
Breakage syndrome (NBS), which features chromosom- 
al instability, radiosensitivity, immunodeficiency and 
microcephaly (Seemanovfi 1990; Taalman et al. 1989), 
and the ATFRESNO variant, which involves all A-T char- 
acteristics together with microcephaly and mental retar- 
dation (Curry et al. 1989). 
Since microcephaly appears to be a common denomi- 
nator in many of these syndromes, we were intrigued by 
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Table 5. Lod scores between A-T and 11@3 loci in various A-T families a 
Locus/family 0 
10 -6 0.05 0.10 0.20 0.30 0.40 
Omax Zm,~. 
STMY 
ISAT01 -0.760 0.054 0.189 0.276 0.229 0.116 0.207 0.276 
ISAT03 0.131 0.104 0.080 0.042 0.017 0.0 10 -6 0.131 
ISAT09 1.826 3.073 3.019 2.555 1.870 1.013 0.062 3.082 
Cumulative (Arab families) 1.196 3.230 3.288 2.873 2.145 1.132 0.082 3.303 
ISAT08 0.793 0.710 0.626 0.456 0.288 0.129 10 6 0.793 
DllS132 
ISAT01 2.802 2.268 1.797 0.985 0.358 0.045 10 .6 2.802 
ISAT03 1.869 1.669 1.465 1.044 0.612 0.205 10 -6 1.869 
ISAT09 0.159 0.133 0.108 0.064 0.030 0.001 10 .6 0.159 
Cumulative (Arab families) 4.830 4.070 3.370 2.093 0.999 0.257 10 -6 4.830 
ISAT08 -12.434 -1.878 -1.099 -0.438 -0.157 -0.034 0.5 0.0 
DllS144 
ISAT01 1.456 1.110 0.797 0.335 0.036 -0.062 10 .6 1.456 
ISAT03 1.957 1.754 1.547 1.121 0.679 0.241 10 .6 1.957 
ISAT09 NI b 
Cumulative (Arab families) 3.413 2.864 2.344 1.456 O. 715 O. 179 10 .6 3.413 
ISAT08 -5.662 -0.960 -0.657 -0.357 -0.186 -0.074 0.5 0.0 
DllS351 
ISAT01 4.136 4.282 3.844 2.681 1.449 0.432 10 6 4.136 
ISAT03 0.930 0.811 0.692 0.458 0.239 0.067 10 .6 0.930 
ISAT09 1.072 0.972 0.869 0.657 0.440 0.221 10 -6 1.072 
Cumulative (Arab families) 6.138 6.065 5.405 3.796 2.128 O. 720 10-6 6.138 
ISAT08 -4.690 -0.983 -0.676 -0.367 -0.191 -0.074 0.5 0.0 
CD3-G 
ISAT01 -6.755 -1.118 -0.688 -0.448 -0.325 -0.158 0.5 0.0 
ISAT03 0.722 0.645 0.564 0.391 0.213 0.062 10 .6 0.725 
ISAT09 -8.098 0.193 0.603 0.753 0.602 0.329 0.183 0.757 
Cumulative (Arab families) -14.131 -0.280 0.479 0.696 0.490 0.233 0.175 0.710 
ISAT08 1.244 1.113 0.980 0.715 0.461 0.224 10 6 1.244 
a For family ISAT9 the given values of 0 and Z were calculated considering VI-2, VI-3, VI-5, VI-6, VI-8, VI-10, and VI-11 as affected 
b NI, Not informative 
its appearance in our AMC patients. However,  our search 
for similarit ies between AMC and A-T  in addit ion to 
ataxia revea led no further resemblance between the two 
diseases at e i ther the clinical or  the cel lular level. I t  
should also be noted that cataract is not  character ist ic of
any of the above diseases. Fur ther  evidence for this dif- 
ferent iat ion was obta ined from l inkage analysis, which 
indicated that the two diseases are clearly not l inked 
genetical ly. The occurrence of these two autosomal  re- 
cessive diseases in family ISAT9 is thus fortuitous, and 
probab ly  reflects the high degree of inbreeding in this 
pedigree.  
The di f ferent iat ion of AMC from A-T,  and the iden- 
t i f ication of  V I -3  as being affected by both,  enabled us 
to extract,  f rom family ISAT9,  the maximal  amount  of  
l inkage informat ion with regard to A-T .  The results in 
the 3 Arab  A -T  (group A)  famil ies corroborate  those 
that were obta ined in other  ethnic groups, and that lo- 
calized the ATA gene to a 4 cent iMorgan (male-specif-  
ic) interval  at 11@3, f lanked on the centromer ic  side 
by STMY/D11S35/D11S385, and on the distal side by 
NCAM/DRD2 (Gatt i  et al. 1988; McConvi l le  et al. 
1990a, b; Sanal et al. 1990). Ev idence support ing the 
local izat ion of  the A -T  gene of family ISAT8 alone to 
chromosome 11q23 could not  be obta ined;  this awaits 
new markers  more  t ightly l inked to A-T ,  and the even- 
tual isolat ion of the A -T  genes. Unt i l  this quest ion is re- 
solved, our  data indicate the need for caution in applying 
the present ly  avai lable 1 lq23 markers  for diagnostic pur-  
poses in A -T  famil ies not assigned to specific comple-  
mentat ion  groups. 
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